Evertec (EVTC) Competitors

Medpace (NASDAQ:MEDP) and Evertec (NYSE:EVTC) are both mid-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

Which has better valuation and earnings, MEDP or EVTC?

Medpace has higher revenue and earnings than Evertec. Evertec is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.16B	4.16	$404.39M	$13.10	23.81
Evertec	$868.96M	2.44	$112.62M	$1.99	16.73

Which has more volatility and risk, MEDP or EVTC?

Medpace has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, Evertec has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in MEDP or EVTC?

78.0% of Medpace shares are held by institutional investors. Comparatively, 96.8% of Evertec shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 0.6% of Evertec shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Do analysts rate MEDP or EVTC?

Medpace presently has a consensus price target of $344.82, suggesting a potential upside of 10.56%. Evertec has a consensus price target of $39.00, suggesting a potential upside of 17.15%. Given Evertec's stronger consensus rating and higher probable upside, analysts plainly believe Evertec is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.21
Evertec	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the media favor MEDP or EVTC?

In the previous week, Medpace had 3 more articles in the media than Evertec. MarketBeat recorded 11 mentions for Medpace and 8 mentions for Evertec. Medpace's average media sentiment score of 1.16 beat Evertec's score of 0.97 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	8 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Evertec	4 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MEDP or EVTC more profitable?

Medpace has a net margin of 19.31% compared to Evertec's net margin of 14.89%. Medpace's return on equity of 54.36% beat Evertec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	19.31%	54.36%	20.81%
Evertec	14.89%	38.45%	10.24%

Summary

Medpace beats Evertec on 12 of the 15 factors compared between the two stocks.